Biopol Chemicals Ltd Financials
Company Logo

Biopol Chemicals Ltd Financial Statement

Biopol Chemicals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Biopol Chemicals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual49.13
Operating Expenses Annual42.59
Operating Profit Annual6.56
Interest Annual0.68
Depreciation0.07
Net Profit Annual4.34
Tax Annual1.46

Biopol Chemicals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.08
Cash Flow from Operations-2.34
Cash Flow from Investing-0.02
Cash Flow from Financing3.43
Cash Flow at the End1.15

Biopol Chemicals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)13.35
PBIT Margin (%)13.21
PBT Margin (%)-6.19
Net PROFIT Margin (%)8.83
Return On Networth / Equity (%)38.17
Return On Networth /Employed (%)38.01
Return On Assets (%)25.44
Total Debt / Equity (X)0.49
Asset Turnover Ratio (%)2.88

Biopol Chemicals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.23
Total Current Assets Annual31.20
Non Current Assets Annual0.27
Total Shareholders Funds Annual13.54
Total Assets Annual31.48

Biopol Chemicals Ltd Earning Calls

No Data Availabe

FAQS on Biopol Chemicals Ltd Financials

As of Feb 20, 2026, Biopol Chemicals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Biopol Chemicals Ltd is not with a debt-to-equity ratio of 0.57.

In FY 2025 , Biopol Chemicals Ltd recorded a total revenue of approximately 49.13 Cr marking a significant milestone in the company's financial performance.

Biopol Chemicals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 1.0% annually, respectively..

Biopol Chemicals Ltd's current PE ratio is .

Biopol Chemicals Ltd's ROCE averaged 22.5% from the FY ending March 2024 to 2025, with a median of 22.5%. It peaked at 30.6% in March 2025, reflecting strong capital efficiency over the period..

Biopol Chemicals Ltd's latest EBIT is Rs. 6.48 Cr, surpassing the average EBIT of Rs. 4.15 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions